Literature DB >> 8712901

The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions.

P Valenstein1, M Pfaller, M Yungbluth.   

Abstract

OBJECTIVE: To examine the efficiency with which physicians use routine stool microbiology tests.
DESIGN: Questionnaire and structured review of 100 consecutive stool bacteriology and parasitology examinations at each participating institution.
SETTING: Six hundred one institutions enrolled in the College of American Pathologists Q-probes Program.
RESULTS: Of 59500 bacteriology specimens, 3808 (6.4%) contained a pathogen. The vast majority (99%) of bacterial pathogens were detected in either the first or second specimen submitted. Almost 40% of inpatient specimens were collected after the third day of hospitalization, but only 0.6% of these specimens were positive for enteric pathogens that had not been previously recovered. More than half of the laboratories reported having no limits on the number of bacteriology specimens per patient that could be submitted for testing, and fewer than 8% of laboratories rejected specimens from inpatients after a certain number of days in the hospital. The frequency with which laboratories performed tests for Clostridium difficile varied widely. Of 58500 parasitology specimens, 1463 (2.5%) contained a pathogen; 97.6% of pathogens were detected by the second stool specimen, and 99.8% were detected by the third specimen. Only 0.7% of specimens from inpatients hospitalized more than 4 days contained a new pathogen.
CONCLUSIONS: We recommend that no more than two bacteriology specimens and no more that two or three parasitology specimens be processed per patient without consultation. Standard stool examination for a bacterial pathogens has a low yield and should not be performed after 3 days of hospitalization. Likewise, parasitology examinations should not be performed after 4 days of hospitalization.

Entities:  

Mesh:

Year:  1996        PMID: 8712901

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  18 in total

1.  A survey of stool culturing practices for vibrio species at clinical laboratories in Gulf Coast states.

Authors:  N N Marano; N A Daniels; A N Easton; A McShan; B Ray; J G Wells; P M Griffin; F J Angulo
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Recognition and prevention of hospital-associated enteric infections in the intensive care unit.

Authors:  Linda D Bobo; Erik R Dubberke
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

3.  Diarrhoea developing in hospital patients.

Authors:  R M McLoughlin; H J O'Connor
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

4.  Fecal lactoferrin screening assay for inflammatory bacterial diarrhea.

Authors:  I Nachamkin
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized Patients.

Authors:  D Nikolic; S S Richter; K Asamoto; R Wyllie; R Tuttle; G W Procop
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

6.  Optimizing Test Utilization in the Clinical Microbiology Laboratory: Tools and Opportunities.

Authors:  Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

7.  Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus.

Authors:  John M Boyce; Nancy L Havill; Benedicte Maria
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  Fecal leukocyte stain has diagnostic value for outpatients but not inpatients.

Authors:  K L Savola; E J Baron; L S Tompkins; D J Passaro
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

9.  [Diagnostic workup and therapy of infectious diarrhea. Current standards].

Authors:  A Stallmach; S Hagel; A W Lohse
Journal:  Internist (Berl)       Date:  2015-12       Impact factor: 0.743

10.  Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings.

Authors:  A J Morris; P R Murray; L B Reller
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.